CASE DISCUSSION
Nutrition in liver disease
Presented India by Dr. Daphnee D. K.Views
4,307
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
In liver disease, moderate protein intake helps prevent excessive ammonia production, supporting liver function. A balanced diet with controlled carbohydrates and healthy fats aids energy production and avoids excessive stress on the liver. Proper vitamin and mineral supplementation address...
Case Summary
- The webinar focuses on the learning objectives related to malnutrition in liver disease, including prevalence, causes, patterns, and consequences. It aims to help healthcare professionals recognize nutrition problems and understand the pathophysiology behind sarcopenia in liver disease, and learn to use nutrition screening and assessment tools to determine the risk of poor clinical outcomes due to sarcopenia. Treatment strategies to optimize patients with liver disease were discussed.
Speaker Profile
Dr. Daphnee D. K.
Chief Clinical Dietitian, Head, Dept of Dietetics, Apollo Hospitals, ChennaiDr. Daphnee brings 25 years of clinical experience from Apollo Hospitals, Greams Road, Chennai, and holds a PhD in Clinical Nutrition. Her research focuses on analyzing nutritional deficits in Indian adult patients with end-stage liver disease and the impact of nutritional support on peri- and post-liver transplant outcomes. She has received several accolades, including the CMO Asia Award in 2017 for her quality initiative on combating hospital malnutrition, and the Apollo Clinical Excellence Award in 2018 for her pivotal role in developing the Digital Dietitian Module to digitalize the nutrition care process. Dr. Daphnee has contributed to national and international publications, reviewed the Journal of Enteral and Parenteral Nutrition, and serves as the Course Director for the Apollo Clinical Nutrition & Dietetics Internship Program. Additionally, she is a member of the Board of Studies at the University of Madras.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.